Effect of penbutolol on neuroendocrine responses to buspirone and mood in SSRI-Refractory patients: A preliminary study

Human Psychopharmacology

Volumn 14, Issue 4, 1999, Pages 273-277

  Clifford, E M ^a,b   Whale, R ^b   Sharp, T ^b   Cohen, P J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b WARNEFORD HOSPITAL   (United Kingdom)

Author keywords

blockers; Depression; Penbutolol; Serotonin

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; PENBUTOLOL; SEROTONIN 1A ANTAGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; MOOD; NEUROENDOCRINE SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032972247     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199906)14:4<273::AID-HUP90>3.0.CO;2-X     Document Type: Article

References (17)

1. Anderson, I. M. and Cowen, P. J. (1992). Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. Psychopharmacology, 106, 428-432.
2. Artigas, F. (1995). Pindolol, 5-hydroxytryptamine and antidepressant augmentation. Archives of General Psychiatry, 52, 969-971.
3. Bakish, D., Hooper, C. L., Thornton, M. D., Wiens, A., Miller, C. A. and Thibaudeau, C. A. (1997). Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. International Clinical Psychopharmacology, 12, 91-97.
4. Blier, P. and Bergeron, R. (1995). Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. Journal of Clinical Psychopharmacology, 15, 217-222.
5. 1A receptors induces rapid antidepressant response. Neuropsychopharmacology, 316, 333-338.
6. Bordet, R., Thomas, P. and Dupuis, B. (1998). Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. American Journal of Psychiatry, 155, 1346-1351.
7. 1A autoreceptor in vivo. British Journal of Pharmacology, 124, 206-212.
8. Cowen, P. J. (1993). Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clinical Neuropharmacology, 16(Suppl. 3), S6-S18.
9. 1A receptor sensitivity in major depression: a neuroendocrine study with buspirone. British Journal of Psychiatry, 164, 372-379.
10. Dinan, T. G. and Scott, L. V. (1996). Does pindolol induce a rapid improvement in depressed patients resistant to serotonin re-uptake inhibitors? Journal of Serotonin Research, 3, 19-21.
11. Gartside, S. E., Clifford, E. M., Cowen, P. J. and Sharp, T. (in press). Effects of (-)-tertatolol, (-)-penbutolol, and (±) pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study. British Journal of Pharmacology.
12. Gundlah, C., Hjorth, S. and Auerbach, S. B. (1997). Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology, 36, 475-482.
13. Hjorth, S. and Carlsson, A. (1986). Is pindolol a mixed agonist, antagonist at central serolonin (5-HT) receptors? European Journal of Pharmacology, 129, 131-138.
14. Meitzer, H. Y. and Maes, M. I. (1994). Effects of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man. Psychopharmacology, 114, 635-643.
15. Perez, V., Gilaberte, I., Faries, D., Alvarez, E. and Artigas, F. (1997). Randomised, double-blind, placebo controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet, 349, 1594-1597.
16. Tome, M. B., Isaac, M. T. and Holland, C. (1997). Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. International Clinical Psychopharmacology, 12, 81-89.
17. Vinar, O., Vinarova, E. and Horacek, J. (1996). Pindolol accelerates the therapeutic action of selective serotonin reuptake inhibitors (SSRI) in depression. Homeostasis, 37, 93-95.